FDA: AstraZeneca rollout to proceed despite South Africa suspension

The FDA assured that the rollout of AstraZeneca's COVID-19 vaccine in the Philippines will proceed as planned.

Director General Eric Domingo stated that the variant prevalent in the country is similar to the original strain used in developing the AstraZeneca vaccine, making it effective against local variants.

Despite South Africa suspending its use due to lower efficacy against new variants, Domingo emphasized that these variants are not dominant in the Philippines.